Latest News

Germany to pump €1bn into breakthrough innovation

German Research Minister Anja Karliczek and Economics Minister Peter Altmaier make a joint statement on the founding of the Agency for Jump Innovations following the meeting of the Federal Cabinet. © BMBF / Hans-Joachim Rickel


by tg

Germany’s government announced that it will create an agency for breakthrough ("jump") innovation to foster technology transfer of risky research projects with high market potential into products.

The German agency precede EU plans to create a similar EU agency within its next research framework programme starting in 2021. The agency will be funded with roughly €1bn over 10 years.

The move is intented to keep value creation in Germany.  The idea for such an agency is lent from the US agency DARPA (Defense Advanced Research Projects Agency), which was founded by President Dwight D. Eisenhower in the 1950ies to support commercialisation of groundbreaking inventions such as the Internet, GPS or driverless vehicles. Besides Germany, Sweden and Switzerland have already established innovation agencies for non-military purposes. 

The German agency is set to start next year. According to Germany’s minister for economics, Peter Altmaier, a first call will seek for 3 to 4 promising artificial intelligence projects.

Moderna set to deliver COVID-19 jab to the EU

The EU is continuing its COVID-19 vaccine shopping spree to supply member states with enough doses to vaccinate its entire population with a...

Danish Galecto Inc. secures US$64m equity financing

The financing round was co-led by Eir Ventures. Seed investor Novo Holdings, and new and existing investors such as OrbiMed, Ysios Capital, HBM...

BioNTech and Fosun Pharma kick off Chinese COVID-19 trials

In principle, the extended Phase I safety trial will copy a successful safety trial conducted with the modified mRNA COVID-19 vaccine BNT162b1 that...

Unilever to replace fossil carbon in cleaning products

The investment is part of Unilever’s new ‘Clean Future’ initiative aims at replacing 100% of the carbon derived from fossil fuels in the company’s...

Illumina and Epidarex Capital invest in post-Brexit UK

Epidarex Capital’s (Edinburgh) oversubscribed £102m UK life sciences VC fund was backed by a £50m investment from the British Business Bank, who is...

Biotechs request money for COVID therapeutics

The initiative of BIO Deutschland could become a blueprint for Europe. German COVID-19 therapy developers have recommended to set up a fund to...

COVID-19: Siemens’ assay outperforms antibody tests from competitors

For Germany’s government, it is bad news: to establish immunity passports aimed at identifying people who have developed antibodies against...